Forskning ved Københavns Universitet - Københavns Universitet


Trans-dichlorooxovandium (IV) complex as a novel photoinducible DNA interstrand crosslinker for cancer therapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Kumar Somyajit
  • Bhabatosh Banik
  • Sneha Saxena
  • Sharath Babu
  • Manoor Prakash Hande
  • Akhil R Chakravarty
  • Ganesh Nagaraju

Although DNA interstrand crosslinking (ICL) agents such as mitomycin C, cisplatin and psoralen serve as potent anticancer drugs, these agents are known to have dose-limiting toxic effects on normal cells. Moreover, tumor resistance to these agents has been reported. Here, we show that trans-dichlorooxovanadium (IV) complex of pyrenyl terpyridine (VDC) is a novel photoinducible DNA crosslinking agent. By a combination of in vitro and ex vivo experiments including plasmid-based assays, we find that VDC forms monoadducts on the DNA and can be activated by UV-A and visible light to generate DNA interstrand crosslinks. VDC efficiently activates Fanconi anemia (FA) pathway of DNA interstrand crosslink repair. Strikingly, photoinduction of VDC induces prolonged activation of cell cycle checkpoint and a high degree of cell death in homologous recombination (HR)/ICL repair defective cells. Moreover, VDC specifically targets cells that express pathological RAD51C mutants. These data imply that VDC can be potentially used for cancer therapy and suggest that tumors arising in patients with gene mutations in FA and HR repair pathway can be specifically targeted by a photoactivatable VDC.

Udgave nummer2
Sider (fra-til)145-56
Antal sider12
StatusUdgivet - feb. 2016
Eksternt udgivetJa

ID: 165939702